- Home
- MYGN vs HFWA Comparison
MYGN vs HFWA Comparison
Compare MYGN & HFWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- HFWA
- Stock Information
- Founded
- MYGN 1991
- HFWA 1927
- Country
- MYGN United States
- HFWA United States
- Employees
- MYGN N/A
- HFWA N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- HFWA Banks
- Sector
- MYGN Health Care
- HFWA Finance
- Exchange
- MYGN Nasdaq
- HFWA Nasdaq
- Market Cap
- MYGN 744.7M
- HFWA 843.8M
- IPO Year
- MYGN 1995
- HFWA N/A
- Fundamental
- Price
- MYGN $4.13
- HFWA $23.93
- Analyst Decision
- MYGN Hold
- HFWA Hold
- Analyst Count
- MYGN 16
- HFWA 3
- Target Price
- MYGN $16.40
- HFWA $27.67
- AVG Volume (30 Days)
- MYGN 3.4M
- HFWA 215.8K
- Earning Date
- MYGN 05-06-2025
- HFWA 04-24-2025
- Dividend Yield
- MYGN N/A
- HFWA 3.98%
- EPS Growth
- MYGN N/A
- HFWA 11.50
- EPS
- MYGN N/A
- HFWA 1.48
- Revenue
- MYGN $831,300,000.00
- HFWA $220,859,000.00
- Revenue This Year
- MYGN N/A
- HFWA $23.49
- Revenue Next Year
- MYGN $7.21
- HFWA $7.68
- P/E Ratio
- MYGN N/A
- HFWA $16.39
- Revenue Growth
- MYGN 7.38
- HFWA 0.16
- 52 Week Low
- MYGN $3.98
- HFWA $16.55
- 52 Week High
- MYGN $29.30
- HFWA $27.58
- Technical
- Relative Strength Index (RSI)
- MYGN 25.47
- HFWA 57.57
- Support Level
- MYGN $3.81
- HFWA $23.94
- Resistance Level
- MYGN $4.31
- HFWA $24.35
- Average True Range (ATR)
- MYGN 0.47
- HFWA 0.62
- MACD
- MYGN -0.16
- HFWA 0.13
- Stochastic Oscillator
- MYGN 8.00
- HFWA 61.92
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About HFWA Heritage Financial Corporation
Heritage Financial Corp is a bank holding company. The company through its subsidiary provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as noninterest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.